{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:11:39Z","timestamp":1793211099183,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"DOI":"10.1007\/s11882-025-01249-y","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T01:35:28Z","timestamp":1767490528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Review of Adenosine Deaminase 2 (ADA2) as a Biomarker of Monocyte\/Macrophage Activation"],"prefix":"10.1007","volume":"26","author":[{"given":"Jamie","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hershfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Tarrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"3","key":"1249_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0009-8981(81)90247-3","volume":"115","author":"H Ratech","year":"1981","unstructured":"Ratech H, Hirschhorn R. Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency. Clin Chim Acta. 1981;115(3):341\u20137.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1249_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/BC.2006.042","volume":"387","author":"S Iwaki-Egawa","year":"2006","unstructured":"Iwaki-Egawa S, Yamamoto T, Watanabe Y. Human plasma adenosine deaminase 2 is secreted by activated monocytes. Biol Chem. 2006;387(3):319\u201321.","journal-title":"Biol Chem"},{"issue":"7","key":"1249_CR3","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/clinchem\/38.7.1322","volume":"38","author":"JP Ungerer","year":"1992","unstructured":"Ungerer JP, Oosthuizen HM, Bissbort SH, Vermaak WJ. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992;38(7):1322\u20136.","journal-title":"Clin Chem"},{"issue":"1","key":"1249_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1073\/pnas.75.1.446","volume":"75","author":"WP Schrader","year":"1978","unstructured":"Schrader WP, Pollara B, Meuwissen HJ. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Proc Natl Acad Sci U S A. 1978;75(1):446\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7786","key":"1249_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","volume":"2","author":"ER Giblett","year":"1972","unstructured":"Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972;2(7786):1067\u20139.","journal-title":"Lancet"},{"issue":"2","key":"1249_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0005-2744(81)90298-9","volume":"658","author":"PE Daddona","year":"1981","unstructured":"Daddona PE, Kelley WN. Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts. Biochim Biophys Acta. 1981;658(2):280\u201390.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1249_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921\u201331.","journal-title":"N Engl J Med"},{"issue":"10","key":"1249_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320.","journal-title":"N Engl J Med"},{"issue":"8","key":"1249_CR9","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp J, Proietti M, Frede N, Buchta M, Hubscher K, Rojas Restrepo J, et al. Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol. 2017;69(8):1689\u2013700.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1249_CR10","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/MPH.0000000000000805","volume":"39","author":"H Hashem","year":"2017","unstructured":"Hashem H, Egler R, Dalal J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017;39(5):e293\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1249_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","volume":"177","author":"T Ben-Ami","year":"2016","unstructured":"Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, et al. Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr. 2016;177:316\u201320.","journal-title":"J Pediatr"},{"issue":"11\u201312","key":"1249_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/21678707.2021.2050367","volume":"9","author":"TK Tarrant","year":"2021","unstructured":"Tarrant TK, Kelly SJ, Hershfield MS. Elucidating the pathogenesis of adenosine deaminase 2 deficiency: current status and unmet needs. Expert Opin Orphan D. 2021;9(11\u201312):257\u201364.","journal-title":"Expert Opin Orphan D"},{"issue":"3","key":"1249_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ajh.2830370303","volume":"37","author":"JG Niedzwicki","year":"1991","unstructured":"Niedzwicki JG, Mayer KH, Abushanab E, Abernethy DR. Plasma adenosine deaminase2 is a marker for human immunodeficiency virus-1 seroconversion. Am J Hematol. 1991;37(3):152\u20135.","journal-title":"Am J Hematol"},{"issue":"5","key":"1249_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1182\/blood.V72.5.1627.1627","volume":"72","author":"H Ratech","year":"1988","unstructured":"Ratech H, Martiniuk F, Borer WZ, Rappaport H. Differential expression of adenosine deaminase isozymes in acute leukemia. Blood. 1988;72(5):1627\u201332.","journal-title":"Blood"},{"issue":"2","key":"1249_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/annrheumdis-2019-216030","volume":"79","author":"PY Lee","year":"2020","unstructured":"Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, et al. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2020;79(2):225\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1249_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88(2):279\u201390.","journal-title":"J Leukoc Biol"},{"key":"1249_CR17","doi-asserted-by":"crossref","unstructured":"Ganesan N, Ronsmans S, Vanoirbeek J, Hoet PHM. Assessment of experimental techniques that facilitate human granuloma formation in an in vitro system: A systematic review. Cells. 2022;11(5).","DOI":"10.3390\/cells11050864"},{"issue":"15","key":"1249_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.21037\/atm.2016.07.23","volume":"4","author":"JM Porcel","year":"2016","unstructured":"Porcel JM. Advances in the diagnosis of tuberculous pleuritis. Ann Transl Med. 2016;4(15):282.","journal-title":"Ann Transl Med"},{"issue":"4","key":"1249_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jinf.2013.05.009","volume":"67","author":"LT Keng","year":"2013","unstructured":"Keng LT, Shu CC, Chen JY, Liang SK, Lin CK, Chang LY, et al. Evaluating pleural ADA, ADA2, IFN-\u03b3 and IGRA for diagnosing tuberculous pleurisy. J Infect. 2013;67(4):294\u2013302.","journal-title":"J Infect"},{"issue":"4","key":"1249_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/15216549700204581","volume":"43","author":"FJ Al-Shammary","year":"1997","unstructured":"Al-Shammary FJ. Adenosine deaminase activity in serum and pleural effusions of tuberculous and non-tuberculous patients. IUBMB Life. 1997;43(4):763\u201379.","journal-title":"IUBMB Life"},{"issue":"2","key":"1249_CR21","first-page":"79","volume":"2","author":"BK Gupta","year":"2010","unstructured":"Gupta BK, Bharat V, Bandyopadhyay D. Role of adenosine deaminase estimation in differentiation of tuberculous and non-tuberculous exudative pleural effusions. J Clin Med Res. 2010;2(2):79\u201384.","journal-title":"J Clin Med Res"},{"issue":"5","key":"1249_CR22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.rmed.2007.12.007","volume":"102","author":"Q-L Liang","year":"2008","unstructured":"Liang Q-L, Shi H-Z, Wang K, Qin S-M, Qin X-J. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008;102(5):744\u201354.","journal-title":"Respir Med"},{"issue":"4","key":"1249_CR23","first-page":"321","volume":"5","author":"M Gorguner","year":"2000","unstructured":"Gorguner M, Cerci M, Gorguner I. Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions. Respirology. 2000;5(4):321\u20134.","journal-title":"Respirology"},{"issue":"1","key":"1249_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/2049-6958-9-12","volume":"9","author":"S Yurt","year":"2014","unstructured":"Yurt S, K\u00fc\u00e7\u00fckergin C, Yigitbas BA, Se\u00e7kin S, Tigin HC, Ko\u015far AF. Diagnostic utility of serum and pleural levels of adenosine deaminase 1\u20132, and interferon-\u03b3 in the diagnosis of pleural tuberculosis. Multidiscip Respir Med. 2014;9(1):12.","journal-title":"Multidiscip Respir Med"},{"issue":"2","key":"1249_CR25","first-page":"214","volume":"13","author":"AE Zemlin","year":"2009","unstructured":"Zemlin AE, Burgess LJ, Carstens ME. The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions. Int J Tuberc Lung Dis. 2009;13(2):214\u201320.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1249_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7078652","author":"TT Zeng","year":"2022","unstructured":"Zeng TT, Ling B, Hu XR, Wang SY, Qiao WL, Gao LJ, et al. The value of adenosine deaminase 2 in the detection of tuberculous pleural effusion: a meta-analysis and systematic review. Can Respir J. 2022. https:\/\/doi.org\/10.1155\/2022\/7078652.","journal-title":"Can Respir J"},{"issue":"4","key":"1249_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1183\/09031936.96.09040747","volume":"9","author":"L Vald\u00e9s","year":"1996","unstructured":"Vald\u00e9s L, San Jos\u00e9 E, Alvarez D, Valle JM. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J. 1996;9(4):747\u201351.","journal-title":"Eur Respir J"},{"issue":"1","key":"1249_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4046\/trd.2017.80.1.77","volume":"80","author":"MJ Bae","year":"2017","unstructured":"Bae MJ, Ryu S, Kim HJ, Cha SI, Kim CH, Lee J. Mycobacterium tuberculosis ESAT6 and CPF10 induce adenosine deaminase 2 mRNA expression in monocyte-derived macrophages. Tuberc Respir Dis (Seoul). 2017;80(1):77\u201382.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"1249_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2020.101940","volume":"123","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Ryu S, Choi SH, Seo H, Yoo SS, Lee SY, et al. Comparison of biochemical parameters and chemokine levels in pleural fluid between patients with anergic and non-anergic tuberculous pleural effusion. Tuberculosis. 2020;123:101940.","journal-title":"Tuberculosis"},{"issue":"1","key":"1249_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1378\/chest.77.1.4","volume":"77","author":"DN McMurray","year":"1980","unstructured":"McMurray DN. Mechanisms of anergy in tuberculosis. Chest. 1980;77(1):4\u20135.","journal-title":"Chest"},{"issue":"2","key":"1249_CR31","first-page":"147","volume":"2","author":"D Orphanidou","year":"1998","unstructured":"Orphanidou D, Stratakos G, Rasidakis A, Toumbis M, Samara J, Bakakos P, et al. Adenosine deaminase activity and lysozyme levels in Bronchoalveolar lavage fluid in patients with pulmonary tuberculosis. Int J Tuberc Lung D. 1998;2(2):147\u201352.","journal-title":"Int J Tuberc Lung D"},{"issue":"7","key":"1249_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1053\/rmed.2001.1284","volume":"96","author":"O Kayacan","year":"2002","unstructured":"Kayacan O, Karnak D, Delibalta M, Beder S, Karaca L, Tutkak H. Adenosine deaminase activity in bronchoalveolar lavage in Turkish patients with smear negative pulmonary tuberculosis. Respir Med. 2002;96(7):536\u201341.","journal-title":"Respir Med"},{"issue":"6","key":"1249_CR33","first-page":"744","volume":"13","author":"K Dimakou","year":"2009","unstructured":"Dimakou K, Hillas G, Bakakos P. Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2009;13(6):744\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1249_CR34","doi-asserted-by":"publisher","first-page":"725447","DOI":"10.3389\/fimmu.2021.725447","volume":"12","author":"EM Delemarre","year":"2021","unstructured":"Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, et al. Serum biomarker profile including CCL1, CXCL10, VEGF, and adenosine deaminase activity distinguishes active from remotely acquired latent tuberculosis. Front Immunol. 2021;12:725447.","journal-title":"Front Immunol"},{"issue":"5","key":"1249_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jcla.1033","volume":"15","author":"C-M Schutte","year":"2001","unstructured":"Schutte C-M, Ungerer JPJ, du Plessis H, van der Meyden CH. Significance of cerebrospinal fluid adenosine deaminase isoenzymes in tuberculous (TB) meningitis. J Clin Lab Anal. 2001;15(5):236\u20138.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"1249_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.69.1.137","volume":"69","author":"S Eintracht","year":"2000","unstructured":"Eintracht S, Silber E, Sonnenberg P, Koornhof HJ, Saffer D. Analysis of adenosine deaminase isoenzyme-2 (ADA(2)) in cerebrospinal fluid in the diagnosis of tuberculosis meningitis. J Neurol Neurosurg Psychiatry. 2000;69(1):137\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1249_CR37","doi-asserted-by":"crossref","unstructured":"S\u00e8ve P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S et al. Sarcoidosis: A clinical overview from symptoms to diagnosis. Cells. 2021;10(4).","DOI":"10.3390\/cells10040766"},{"issue":"8","key":"1249_CR38","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26\u201351.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1249_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0954-6111(97)90252-3","volume":"91","author":"AF Shorr","year":"1997","unstructured":"Shorr AF, Torrington KG, Parker JM. Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. Respir Med. 1997;91(7):399\u2013401.","journal-title":"Respir Med"},{"issue":"1","key":"1249_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.intimp.2015.01.015","volume":"25","author":"S Gungor","year":"2015","unstructured":"Gungor S, Ozseker F, Yalcinsoy M, Akkaya E, Can G, Eroglu H, et al. Conventional markers in determination of activity of sarcoidosis. Int Immunopharmacol. 2015;25(1):174\u20139.","journal-title":"Int Immunopharmacol"},{"key":"1249_CR41","doi-asserted-by":"crossref","unstructured":"Uysal P, Durmus S, Sozer V, Gelisgen R, Seyhan EC, Erdenen F et al. YKL-40, soluble IL-2 Receptor, angiotensin converting enzyme and C-Reactive protein: comparison of markers of sarcoidosis activity. Biomolecules. 2018;8(3).","DOI":"10.3390\/biom8030084"},{"issue":"21","key":"1249_CR42","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS, Sarcoidosis. N Engl J Med. 2007;357(21):2153\u201365.","journal-title":"N Engl J Med"},{"key":"1249_CR43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/acr.25175","volume":"75","author":"J Shen","year":"2023","unstructured":"Shen J, Doss J, Gurunath RK, Arps K, Milne M, Rampersad R, et al. Pilot study investigating adenosine Deaminase-2 as a disease activity biomarker for cardiac sarcoidosis. Arthritis Rheumatol. 2023;75:2227\u20138.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1249_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1164\/ajrccm\/148.2.483","volume":"148","author":"S Gilbert","year":"1993","unstructured":"Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis. 1993;148(2):483\u20136.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"1249_CR45","first-page":"1763","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. The Journal of Allergy and Clinical Immunology: In Practice. 2019;7(6):1763\u201370.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"key":"1249_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","volume":"11","author":"HE Ho","year":"2020","unstructured":"Ho HE, Cunningham-Rundles C. Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol. 2020;11:149.","journal-title":"Front Immunol"},{"issue":"7","key":"1249_CR47","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s10875-022-01318-1","volume":"42","author":"MSA Fraz","year":"2022","unstructured":"Fraz MSA, Michelsen AE, Moe N, Aalokken TM, Macpherson ME, Nordoy I, et al. Raised serum markers of T cell activation and exhaustion in Granulomatous-Lymphocytic interstitial lung disease in common variable immunodeficiency. J Clin Immunol. 2022;42(7):1553\u201363.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1249_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s10875-020-00947-8","volume":"41","author":"AC van Stigt","year":"2021","unstructured":"van Stigt AC, Dalm VASH, Nagtzaam NMA, van Rijswijk DA, Barendregt BH, van Hagen PM, et al. Soluble interleukin-2 receptor is a promising serum biomarker for granulomatous disease in common variable immune deficiency. J Clin Immunol. 2021;41(3):694\u20137.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1249_CR49","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMra2314005","volume":"392","author":"JI Henter","year":"2025","unstructured":"Henter JI. Hemophagocytic lymphohistiocytosis. N Engl J Med. 2025;392(6):584\u201398.","journal-title":"N Engl J Med"},{"issue":"4","key":"1249_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","volume":"34","author":"G Griffin","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020;34(4):101515.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1249_CR51","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13054-020-02941-3","volume":"24","author":"C Knaak","year":"2020","unstructured":"Knaak C, Nyvlt P, Schuster FS, Spies C, Heeren P, Schenk T, et al. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore. Crit Care. 2020;24(1):244.","journal-title":"Crit Care"},{"issue":"4","key":"1249_CR52","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/ijlh.12334","volume":"37","author":"W Chen","year":"2015","unstructured":"Chen W, Zhang S, Zhang W, Yang X, Xu J, Qiu H, et al. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis. Int J Lab Hematol. 2015;37(4):544\u201350.","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"1249_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","volume":"66","author":"GS Schulert","year":"2015","unstructured":"Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med. 2015;66(1):145\u201359.","journal-title":"Annu Rev Med"},{"issue":"7","key":"1249_CR54","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s10875-023-01521-8","volume":"43","author":"MVE Andriessen","year":"2023","unstructured":"Andriessen MVE, Legger GE, Bredius RGM, van Gijn ME, Hak AE, Muller PCEH, et al. Clinical symptoms, laboratory parameters and long-term follow-up in a National DADA2 cohort. J Clin Immunol. 2023;43(7):1581\u201396.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1249_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29461","volume":"69","author":"VV Iyengar","year":"2022","unstructured":"Iyengar VV, Chougule A, Gowri V, Taur P, Prabhu S, Bodhanwala M, et al. DADA2 presenting as nonimmune hemolytic anemia with recurrent macrophage activation syndrome. Pediatr Blood Cancer. 2022;69(6):e29461.","journal-title":"Pediatr Blood Cancer"},{"key":"1249_CR56","doi-asserted-by":"crossref","unstructured":"Drago E, Garbarino F, Signa S, Grossi A, Schena F, Penco F et al. Case report: susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous Immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.937108"},{"issue":"5","key":"1249_CR57","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, Fredrikson M, St\u00e5l P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547\u201354.","journal-title":"Hepatology"},{"issue":"7","key":"1249_CR58","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.cgh.2017.11.028","volume":"16","author":"ZG Jiang","year":"2018","unstructured":"Jiang ZG, Sandhu B, Feldbrugge L, Yee EU, Csizmadia E, Mitsuhashi S, et al. Serum activity of macrophage-derived adenosine deaminase 2 is associated with liver fibrosis in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2018;16(7):1170\u20132.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1249_CR59","doi-asserted-by":"publisher","first-page":"109897","DOI":"10.1016\/j.celrep.2021.109897","volume":"37","author":"S Tiwari-Heckler","year":"2021","unstructured":"Tiwari-Heckler S, Yee EU, Yalcin Y, Park J, Nguyen DT, Gao W, et al. Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease. Cell Rep. 2021;37(4):109897.","journal-title":"Cell Rep"},{"issue":"1","key":"1249_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.arcmed.2009.10.012","volume":"41","author":"M Aghaei","year":"2010","unstructured":"Aghaei M, Karami-Tehrani F, Salami S, Atri M. Diagnostic value of adenosine deaminase activity in benign and malignant breast tumors. Arch Med Res. 2010;41(1):14\u20138.","journal-title":"Arch Med Res"},{"issue":"1","key":"1249_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00404-012-2279-5","volume":"286","author":"IF Urunsak","year":"2012","unstructured":"Urunsak IF, Gulec UK, Paydas S, Seydaoglu G, Guzel AB, Vardar MA. Adenosine deaminase activity in patients with ovarian neoplasms. Arch Gynecol Obstet. 2012;286(1):155\u20139.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"1249_CR62","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1385\/MO:21:2:187","volume":"21","author":"D Vannoni","year":"2004","unstructured":"Vannoni D, Bernini A, Carlucci F, Civitelli S, Di Pietro MC, Leoncini R, et al. Enzyme activities controlling adenosine levels in normal and neoplastic tissues. Med Oncol. 2004;21(2):187\u201395.","journal-title":"Med Oncol"},{"key":"1249_CR63","doi-asserted-by":"publisher","first-page":"928438","DOI":"10.3389\/fimmu.2022.928438","volume":"13","author":"W Luo","year":"2022","unstructured":"Luo W, Dong L, Chen F, Lei W, He L, Zhou Q, et al. ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer. Front Immunol. 2022;13:928438.","journal-title":"Front Immunol"},{"issue":"2","key":"1249_CR64","first-page":"195","volume":"5","author":"Z Zakeri","year":"2012","unstructured":"Zakeri Z, Izadi S, Niazi A, Bari Z, Zendeboodi S, Shakiba M, et al. Comparison of adenosine deaminase levels in serum and synovial fluid between patients with rheumatoid arthritis and osteoarthritis. Int J Clin Exp Med. 2012;5(2):195\u2013200.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"1249_CR65","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00296-010-1602-3","volume":"32","author":"B Zamani","year":"2012","unstructured":"Zamani B, Jamali R, Ehteram H. Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis. Rheumatol Int. 2012;32(1):183\u20138.","journal-title":"Rheumatol Int"},{"issue":"1","key":"1249_CR66","first-page":"87","volume":"21","author":"RA Sari","year":"2003","unstructured":"Sari RA, Taysi S, Yilmaz O, Bakan N. Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol. 2003;21(1):87\u201390.","journal-title":"Clin Exp Rheumatol"},{"key":"1249_CR67","first-page":"59","volume":"8","author":"SA Khan","year":"2018","unstructured":"Khan SA, Agrawal S, Baral N, Lamsal M. Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients. Psoriasis (Auckl). 2018;8:59\u201363.","journal-title":"Psoriasis (Auckl)"},{"issue":"3","key":"1249_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/ijd.IJD_420_17","volume":"64","author":"YM Moustafa","year":"2019","unstructured":"Moustafa YM, Elsaied MA, Abd-Elaaty EM, Elsayed RA. Evaluation of serum adenosine deaminase and inflammatory markers in psoriatic patients. Indian J Dermatol. 2019;64(3):207\u201312.","journal-title":"Indian J Dermatol"},{"issue":"3","key":"1249_CR69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0190-9622(92)70209-X","volume":"27","author":"T Sasaki","year":"1992","unstructured":"Sasaki T, Nakajima H. Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders. J Am Acad Dermatol. 1992;27(3):411\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1249_CR70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12026-018-8984-9","volume":"66","author":"Z-w Gao","year":"2018","unstructured":"Gao Z-w, Zhao G-h, Zhang Z, Huang J, Li Z-y, Zhang H-z, et al. Serum adenosine deaminase activity is increased in systemic lupus erythematosus patients and correlated with disease activity. Immunol Res. 2018;66(2):299\u2013304.","journal-title":"Immunol Res"},{"issue":"6","key":"1249_CR71","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00296-011-1836-8","volume":"32","author":"R Saghiri","year":"2012","unstructured":"Saghiri R, Ghashghai N, Movaseghi S, Poursharifi P, Jalilfar S, Bidhendi MA, et al. Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern. Rheumatol Int. 2012;32(6):1633\u20138.","journal-title":"Rheumatol Int"},{"issue":"2","key":"1249_CR72","first-page":"225","volume":"37","author":"O Wand","year":"2020","unstructured":"Wand O, Fox BD, Shtraichman O, Moreh-Rahav O, Kramer MR. Non-tuberculous, adenosine deaminase-positive lymphocytic pleural effusion: consider Immunoglobulin G4-related disease. Sarcoidosis Vasc Dif. 2020;37(2):225\u201330.","journal-title":"Sarcoidosis Vasc Dif"},{"issue":"1","key":"1249_CR73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3343\/alm.2023.43.1.108","volume":"43","author":"S Chae","year":"2023","unstructured":"Chae S, Lee J, Cho H, Chae H, Oh EJ. Elevated pleural adenosine deaminase levels in IgG4-related disease with pleural effusion: a case series. Ann Lab Med. 2023;43(1):108\u201310.","journal-title":"Ann Lab Med"},{"issue":"11","key":"1249_CR74","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025162","volume":"100","author":"M Shimoda","year":"2021","unstructured":"Shimoda M, Tanaka Y, Morimoto K, Okumura M, Shimoda K, Takemura T, et al. IgG4-related pleural effusion with high adenosine deaminase levels: a case report and literature review. Medicine (Baltimore). 2021;100(11):e25162.","journal-title":"Medicine (Baltimore)"},{"issue":"16","key":"1249_CR75","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMc1801927","volume":"380","author":"AK Ombrello","year":"2019","unstructured":"Ombrello AK, Qin J, Hoffmann PM, Kumar P, Stone D, Jones A, et al. Treatment strategies for deficiency of adenosine deaminase 2. N Engl J Med. 2019;380(16):1582\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"1249_CR76","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jaci.2021.10.030","volume":"149","author":"NT Deuitch","year":"2022","unstructured":"Deuitch NT, Yang D, Lee PY, Yu X, Moura NS, Schnappauf O, et al. TNF Inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2). J Allergy Clin Immunol. 2022;149(5):1812\u2013e66.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1249_CR77","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","volume":"145","author":"PY Lee","year":"2020","unstructured":"Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020;145(6):1664\u2013e7210.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1249_CR78","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","volume":"135","author":"L Van Eyck Jr","year":"2015","unstructured":"Van Eyck L Jr., Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L, et al. Hematopoietic stem cell transplantation rescues the Immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135(1):283\u2013e75.","journal-title":"J Allergy Clin Immunol"},{"issue":"24","key":"1249_CR79","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, M\u00fcller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130(24):2682\u20138.","journal-title":"Blood"},{"issue":"3","key":"1249_CR80","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jaci.2023.04.014","volume":"152","author":"L Chen","year":"2023","unstructured":"Chen L, Mamutova A, Kozlova A, Latysheva E, Evgeny F, Latysheva T, et al. Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2. J Allergy Clin Immunol. 2023;152(3):771\u201382.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1249_CR81","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jaci.2024.09.007","volume":"155","author":"D Bult\u00e9","year":"2025","unstructured":"Bult\u00e9 D, Barzaghi F, Mesa-Nu\u00f1ez C, Rigamonti C, Basso-Ricci L, Visconti C, et al. Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities. J Allergy Clin Immunol. 2025;155(2):616\u2013. \u2013\u200927.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1249_CR82","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00404-002-0312-9","volume":"267","author":"Y Yoneyama","year":"2003","unstructured":"Yoneyama Y, Suzuki S, Sawa R, Otsubo Y, Miura A, Kuwabara Y, et al. Serum adenosine deaminase activity and its isoenzyme pattern in women with normal pregnancies. Arch Gynecol Obstet. 2003;267(4):205\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"11","key":"1249_CR83","first-page":"1840","volume":"29","author":"K Daglar","year":"2016","unstructured":"Daglar K, Biberoglu E, Kirbas A, Dirican AO, Genc M, Avci A, et al. The cellular immunity and oxidative stress markers in early pregnancy loss. J Matern Fetal Neonatal Med. 2016;29(11):1840\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"1249_CR84","first-page":"7","volume":"9","author":"MT Goodarzi","year":"2010","unstructured":"Goodarzi MT, Abdi M, Tavilani H, Nadi E, Rashidi M. Adenosine deaminase activity in COPD patients and healthy subjects. Iran J Allergy Asthma Immunol. 2010;9(1):7\u201312.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"10","key":"1249_CR85","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","volume":"78","author":"F Minoia","year":"2019","unstructured":"Minoia F, Bovis F, Dav\u00ec S, Horne A, Fischbach M, Frosch M, et al. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2019;78(10):1357\u201362.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01249-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-025-01249-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01249-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:03:00Z","timestamp":1767492180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-025-01249-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1007\/s11882-025-01249-y","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Human<!--Emphasis Type='Bold' removed-->and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2"}}